ClinicalTrials.gov
ClinicalTrials.gov Menu

Common Sensing and Right Ventricular Automatic Capture (COGNATE) (COGNATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01030705
Recruitment Status : Completed
First Posted : December 11, 2009
Last Update Posted : September 29, 2011
Sponsor:
Collaborator:
University of Pittsburgh
Information provided by (Responsible Party):
Boston Scientific Corporation

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study will collect data on features for future pacemakers via an external non-implantable system.

Condition or disease
Bradycardia Chronotropic Incompetence

Detailed Description:
COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Estimated Enrollment : 80 participants
Time Perspective: Retrospective
Official Title: Common Sensing and Right Ventricular Automatic Capture
Study Start Date : November 2009
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010
Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary care clinic patients
Criteria

Inclusion Criteria:

  • Patients who are scheduled to receive either Pacemaker (dual chamber) or CRT-P devices based on physician discretion
  • Patients who are willing and capable of participating in all testing associated with this Clinical Investigation
  • Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

  • Patient enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study
  • Patients with a prosthetic mechanical tricuspid heart valve
  • Women who are pregnant
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01030705


Locations
United States, Iowa
St. Luke's Hospital
Cedar Rapids, Iowa, United States, 52043
United States, Nebraska
Nebraska Heart Institute
Lincoln, Nebraska, United States, 68526
United States, Pennsylvania
University of Pittsburgh Medical Center, Cardiac Electrophysiology
Pittsburgh, Pennsylvania, United States, 15213
United States, Utah
Intermountain Medical Center
Murray, Utah, United States, 84107
United States, Virginia
Virginia Commonwealth University Health System, Medical College of Virginia, MCV Physicians and Hospitals
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Boston Scientific Corporation
University of Pittsburgh
Investigators
Principal Investigator: Samir Saba, MD Health Care Conusltant
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Boston Scientific Corporation
ClinicalTrials.gov Identifier: NCT01030705     History of Changes
Other Study ID Numbers: COGNATE
First Posted: December 11, 2009    Key Record Dates
Last Update Posted: September 29, 2011
Last Verified: September 2011

Keywords provided by Boston Scientific Corporation:
Bradycardia
pacemaker

Additional relevant MeSH terms:
Bradycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes